Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2022

Open Access 01-12-2022 | Research

Effect of chitosan and curcumin nanoparticles against skeletal muscle fibrosis at early regenerative stage of glycerol-injured rat muscles

Authors: Mohamed A. A. Mahdy, Mohamed A. Akl, Fatma A. Madkour

Published in: BMC Musculoskeletal Disorders | Issue 1/2022

Login to get access

Abstract

Introduction

Chitosan and curcumin are natural products that have a wide range of beneficial effects including wound healing. However, their high molecular weight and poor water solubility limit their applications.

Aims

Therefore, the current study aims to evaluate the effects of chitosan (Cs) and curcumin (Cn) nanoparticles (NPs) on fibrosis and regeneration of glycerol-injured muscle.

Methods

Muscle injury was induced by intramuscular injection of glycerol into the tibialis anterior muscle of rats. Cs-NPs and Cn-NPs were administered at different doses intraperitoneally after injury. Injured muscles were collected at day 7 after injury, and muscle fibrosis and regeneration were assessed.

Results

The present results revealed that Cs-NPs and Cn-NPs treatment significantly decreased fibrosis index and increased the average myotube diameter with shifting of the distribution of myotube diameters towards larger diameters in a dose-dependent manner. Immunohistochemical analysis revealed that Cs-NPs and Cn-NPs treatment significantly decreased the number of CD-68+ cells and Col-1+ area. Results showed that Cn-NPs had a higher protective effect, in the form of attenuating muscle fibrosis and inflammation, and enhancing muscle regeneration, than that of Cs-NPs.

Conclusions

To our knowledge, this is the first study to document the effects of Cs-NPs in injured muscles. The results of study might be a novel approach to attenuate muscle fibrosis in humans using curcumin and chitosan nanoparticles.
Literature
1.
Serrano AL, Muñoz-Cánoves P. Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res. 2010;316(18):3050–8.PubMedCrossRef
2.
Wang Z, Tang Z. Composition and function of extracellular matrix in development of skeletal muscle. In: Travascio F, editor. Composition and function of the extracellular matrix in the human body. Rijeka: InTech; 2016. p. 25–43.
3.
Jarvinen TA, Jozsa L, Kannus P, Jarvinen TL, Jarvinen M. Organization and distribution of intramuscular connective tissue in normal and immobilized skeletal muscles. An immunohistochemical, polarization and scanning electron microscopic study. J Muscle Res Cell Motil. 2002;23(3):245–54.PubMedCrossRef
4.
Delaney K, Kasprzycka P, Ciemerych MA, Zimowska M. The role of TGF-β1 during skeletal muscle regeneration. Cell Biol Int. 2017;41(7):706–15.PubMedCrossRef
5.
Murphy S, Ohlendieck K. The extracellular matrix complexome from skeletal muscle. In: Travascio F, editor. Composition and Function of the Extracellular Matrix in the Human Body; 2016. p. 69–92.
6.
Prazeres PHDM, Turquetti AOM, Azevedo PO, Barreto RSN, Miglino MA, Mintz A, et al. Perivascular cell αv integrins as a target to treat skeletal muscle fibrosis. Int J Biochem Cell Biol. 2018;5(99):109–13.CrossRef
7.
Kharraz Y, Guerra J, Pessina P, Serrano AL, Munoz-Canoves P. Understanding the process of fibrosis in Duchenne muscular dystrophy. Biomed Res Int. 2014;2014:11.CrossRef
8.
9.
10.
Mahdy M, Warita K, Hosaka Y. Neutralization of transforming growth factor (TGF)-β1 activity reduced fibrosis and enhanced regeneration of glycerol-injured rat muscle. J Vet Med Sci. 2020;82(2):168–71.PubMedCrossRef
11.
Elieh-Ali-Komi D, Hamblin MR. Chitin and chitosan: production and application of versatile biomedical nanomaterials. Int J Adv Res (Indore). 2016;4(3):411–27.
12.
Rizeq BR, Younes NN, Rasool K, Nasrallah GK. Synthesis, bioapplications, and toxicity evaluation of chitosan-based nanoparticles. Int J Mol Sci. 2019;20(22).
13.
Alsarra IA. Chitosan topical gel formulation in the management of burn wounds. Int J Biol Macromol. 2009;45(1):16–21.PubMedCrossRef
14.
Zhao D, Yu S, Sun B, Gao S, Guo S, Zhao K. Biomedical applications of chitosan and its derivative nanoparticles. Polymers. 2018;10(4):462.PubMedCentralCrossRef
15.
16.
Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cellular and molecular life sciences : CMLS. 2008;65(11):1631–52.PubMedCrossRef
17.
Hewlings SJ, Kalman DS. Curcumin: A review of its' effects on human health. Foods (Basel, Switzerland). 2017;6(10).
18.
Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 1995;49(11):1551–6.PubMedCrossRef
19.
Tanabe Y, Chino K, Sagayama H, Lee HJ, Ozawa H, Maeda S, et al. Effective timing of curcumin ingestion to attenuate eccentric exercise-induced muscle soreness in men. J Nutr Sci Vitaminol. 2019;65(1):82–9.PubMedCrossRef
20.
Huang WC, Chiu WC, Chuang HL, Tang DW, Lee ZM, Wei L, et al. Effect of curcumin supplementation on physiological fatigue and physical performance in mice. Nutrients. 2015;7(2):905–21.PubMedPubMedCentralCrossRef
21.
Tsai S-W, Huang C-C, Hsu Y-J, Chen C-J, Lee P-Y, Huang Y-H, et al. Accelerated muscle recovery after in vivo curcumin supplementation. Nat Prod Commun. 2020;15(1):1934578X20901898.
22.
Liu Y, Chen L, Shen Y, Tan T, Xie N, Luo M, et al. Curcumin ameliorates ischemia-induced limb injury through immunomodulation. Med Sci Monitor : Int Med J Exp Clin Res. 2016;22:2035–42.CrossRef
23.
Kawanishi N, Kato K, Takahashi M, Mizokami T, Otsuka Y, Imaizumi A, et al. Curcumin attenuates oxidative stress following downhill running-induced muscle damage. Biochem Biophys Res Commun. 2013;441(3):573–8.PubMedCrossRef
24.
McFarlin BK, Venable AS, Henning AL, Sampson JN, Pennel K, Vingren JL, et al. Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin. BBA clinical. 2016;5:72–8.PubMedPubMedCentralCrossRef
25.
Avci G, Kadioglu H, Sehirli AO, Bozkurt S, Guclu O, Arslan E, et al. Curcumin protects against ischemia/reperfusion injury in rat skeletal muscle. J Surg Res. 2012;172(1):e39–46.PubMedCrossRef
26.
Thaloor D, Miller KJ, Gephart J, Mitchell PO, Pavlath GK. Systemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Phys. 1999;277(2):C320–9.CrossRef
27.
Islam MM, Shahruzzaman M, Biswas S, Nurus Sakib M, Rashid TU. Chitosan based bioactive materials in tissue engineering applications-a review. Bioactive Materials. 2020;5(1):164–83.PubMedPubMedCentralCrossRef
28.
Lee J. Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: approaches, experimental evidences and theory. Curr Nanosci. 2005;1(3):237–43.CrossRef
29.
Karthikeyan A, Senthil N. Min T. Nanocurcumin: A promising candidate for therapeutic applications. Front Pharmacol; 2020. p. 11.
30.
Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 1997;63(1):125–32.CrossRef
31.
Akl MA, Kartal-Hodzic A, Oksanen T, Ismael HR, Afouna MM, Yliperttula M, et al. Factorial design formulation optimization and in vitro characterization of curcumin-loaded PLGA nanoparticles for colon delivery. J Drug Deliv Sci Technol. 2016;32:10–20.CrossRef
32.
Mahdy MA, Warita K, Hosaka YZ. Early ultrastructural events of skeletal muscle damage following cardiotoxin-induced injury and glycerol-induced injury. Micron. 2016;91:29–40.PubMedCrossRef
33.
Mahdy MA, Warita K, Hosaka YZ. Effects of transforming growth factor-β1 treatment on muscle regeneration and adipogenesis in glycerol-injured muscle. Anim Sci J. 2017;88(11):1811–9.PubMedCrossRef
34.
Kheiri A, Moosawi Jorf SA, Malihipour A, Saremi H, Nikkhah M. Synthesis and characterization of chitosan nanoparticles and their effect on fusarium head blight and oxidative activity in wheat. Int J Biol Macromol. 2017;102:526–38.PubMedCrossRef
35.
Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014;9(2):223–43.PubMedPubMedCentralCrossRef
36.
Fan W, Yan W, Xu Z, Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B: Biointerfaces. 2012;90:21–7.PubMedCrossRef
37.
Abdul Ghafoor Raja M, Katas H, Jing WT. Stability, intracellular delivery, and release of siRNA from chitosan nanoparticles using different cross-linkers. PLoS One. 2015;10(6):e0128963.PubMedCentralCrossRef
38.
Mohamed RM, Yusoh K. A review on the recent research of polycaprolactone (PCL). Adv Mater Res. 2016;1134:249–55.CrossRef
39.
Bartnikowski M, Dargaville TR, Ivanovski S, Hutmacher DW. Degradation mechanisms of polycaprolactone in the context of chemistry, geometry and environment. Prog Polym Sci. 2019;96:1–20.CrossRef
40.
Raveendran R, Bhuvaneshwar G, Sharma CP. In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells. J Biomater Appl. 2013;27(7):811–27.PubMedCrossRef
41.
Tinca AL, Iurian S, Rus LM, Porfire A, Tefas LR. Development and characterization of curcumin-loaded polycaprolactone nanoparticles by Design of Experiments. Ro J Pharm Pract. 2020;13(3):127–38.CrossRef
42.
Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.PubMedCentralCrossRef
43.
Nagy N, Varga Z, Mihály J, Kasza G, Iván B, Kiss É. Highly efficient encapsulation of curcumin into and pH-controlled drug release from poly(μ-caprolactone) nanoparticles stabilized with a novel amphiphilic hyperbranched polyglycerol. J Express Polymer Letters. 2020;14:90–101.CrossRef
44.
Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017;9(4).
45.
Guo F, Guo D, Zhang W, Yan Q, Yang Y, Hong W, et al. Preparation of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles by a microchannel technology. Eur J Pharm Sci. 2017;99:328–36.PubMedCrossRef
46.
Gierszewska M, Ostrowska-Czubenko J. Chitosan-based membranes with different ionic crosslinking density for pharmaceutical and industrial applications. Carbohydr Polym. 2016;153:501–11.PubMedCrossRef
47.
48.
Gosselin LE, McCormick KM. Targeting the immune system to improve ventilatory function in muscular dystrophy. Med Sci Sports Exerc. 2004;36(1):44–51.PubMedCrossRef
49.
Ezhilararasan D, Lakshmi T, Raut B. Novel Nano-based drug delivery systems targeting hepatic stellate cells in the fibrotic liver. J Nanomater. 2021;2021:4674046.CrossRef
50.
El-Denshary E-E-DS, Aljawish A, Nekeety EŒ, AA, Hassan NS, Saleh RH, Rihn BH, Abdel-Wahhab MA. Possible synergistic effect and antioxidant properties of chitosan nanoparticles and quercetin against carbon tetrachloride-induce hepatotoxicity in rats. Soft Nanoscience Letters. 2015;5:36–51.CrossRef
51.
Negm M, Osman N, Barakat L. The role of curcumin – chitosan nanoparticles in the prevention and treatment of liver fibrosis in mice. Alfarama J Basic App Sci. 2021.
52.
Kazemi-Darabadi S, Nayebzadeh R, Shahbazfar AA, Kazemi-Darabadi F, Fathi E. Curcumin and nanocurcumin oral supplementation improve muscle healing in a rat model of surgical muscle laceration. Bull Emerg Trauma. 2019;7(3):292–9.PubMedPubMedCentralCrossRef
53.
Accornero F, Kanisicak O, Tjondrokoesoemo A, Attia AC, McNally EM, Molkentin JD. Myofiber-specific inhibition of TGFβ signaling protects skeletal muscle from injury and dystrophic disease in mice. Hum Mol Genet. 2014;23(25):6903–15.PubMedPubMedCentralCrossRef
54.
Gumucio JP, Flood MD, Phan AC, Brooks SV, Mendias CL. Targeted inhibition of TGF-beta results in an initial improvement but long-term deficit in force production after contraction-induced skeletal muscle injury. J Appl Physiol. 2013;115(4):539–45.PubMedPubMedCentralCrossRef
55.
Zimowska M, Duchesnay A, Dragun P, Oberbek A, Moraczewski J, Martelly I. Immunoneutralization of TGF-β1 improves skeletal muscle regeneration: effects on myoblast differentiation and glycosaminoglycan content. J Cell Biol. 2009;2009:659372.
56.
Kim Y-S, Li Q, Youn H-Y, Kim DY. Oral administration of chitosan attenuates bleomycin-induced pulmonary fibrosis in rats. In Vivo. 2019;33(5):1455–61.PubMedPubMedCentralCrossRef
57.
Hsu YC, Chen MJ, Yu YM, Ko SY, Chang CC. Suppression of TGF-beta1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch Dermatol Res. 2010;302(10):717–24.PubMedCrossRef
58.
Ashrafizadeh M, Zarrabi A, Hushmandi K, Zarrin V, Moghadam ER, Hashemi F, et al. Toward regulatory effects of curcumin on transforming growth factor-beta across different diseases: a review. Front Pharmacol. 2020;11(1785):1–24.
Metadata
Title
Effect of chitosan and curcumin nanoparticles against skeletal muscle fibrosis at early regenerative stage of glycerol-injured rat muscles
Authors
Mohamed A. A. Mahdy
Mohamed A. Akl
Fatma A. Madkour
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2022
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-022-05633-x

Other articles of this Issue 1/2022

BMC Musculoskeletal Disorders 1/2022 Go to the issue

Research

Temporizing cast immobilization is a safe alternative to external fixation in ankle fracture-dislocation while posterior malleolar fragment size predicts loss of reduction: a case control study

Research

Treadmill training mitigates bone deterioration via inhibiting NLRP3/Caspase1/IL-1β signaling in aged rats

Research article

Preoperative prediction of sagittal imbalance in kyphosis secondary to ankylosing spondylitis after one-level three-column osteotomy

Research

Treatment of chronic osteomyelitis with antibiotic-impregnated polymethyl methacrylate (PMMA) – the Cierny approach: is the second stage necessary?

Research

Effectiveness of physiotherapy interventions for back care and the prevention of non-specific low back pain in children and adolescents: a systematic review and meta-analysis

Research

Possible synergic action of non-steroidal anti-inflammatory drugs and glucosamine sulfate for the treatment of knee osteoarthritis: a scoping review